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Background
Type 2 diabetes mellitus (T2DM) is an independent risk
factor for the development of heart failure. Data from
clinical trials have demonstrated that patients with dia-
betic nephropathy have 2-3 times the risk of heart fail-
ure admission than those without nephropathy. Previous
CMR studies have found frequent abnormalities in
patients with T2DM including concentric left ventricular
remodelling (increased relative wall mass), unrecognised
myocardial infarction and raised extracellular volume
(ECV). It is unknown which of these factors predispose
patients to heart failure.
Methods
80 asymptomatic patients with T2DM were recruited
from primary care. All patients underwent CMR at 3.0T
(Philips Achieva TX). Exclusion criteria included known
cardiac disease, kidney disease (eGFR <30), uncontrolled
hypertension, treatment with ACEi/ARB or insulin. 37
patients had persistent microalbuminuria (albumin crea-
tinine ratio (ACR) (>2.5 for men, >3.5 for women on two
or more measurements) and 43 had no documented
microalbuminuria. Standard balanced steady state free
precession cine images were acquired. T1 maps were
acquired precontrast and 15 minutes after administration
of 0.15mmol/kg gadobutrol. T1 maps were acquired
using a an ECG triggered 5(3s)3 modified Look-Locker
inversion recovery acquisition positioned at the short
axis mid ventricular level. LV dimensions were calculated
offline by summation of discs from a short-axis stack and
myocardial extracellular volume calculated by measuring
the pre and post contrast T1 times of myocardium and
blood pool (cvi42 v4.1.3, Circle Cardiovascular Imaging
Inc., Calgary, Canada).
Results
There was no significant difference in patient character-
istics including BMI, diabetes duration, HbA1c or blood
pressure between the ACR +ve and ACR -ve patients
(Table 1).
Measurements of LV geometry including LVEDV,
LVESV, EF, LV mass and relative wall mass (LV mass/
EDV) were not significantly different between the two
groups (Table 2). The incidence of myocardial infarction
in ACR -ve cohort was 7/43 (16.3%) and was similar in
the ACR +ve cohort 6/37 (16.2%). ECV was significantly
higher in the ACR +ve group (27.2±4.2%) than in the
ACR -ve group (25.1±2.8%, P=0.01).
Conclusions
In this cohort of asymptomatic patients with T2DM
there was no difference in concentric remodelling or the
presence of myocardial infarction in patients with and
without microalbuminuria. The only significant differ-
ence was a significantly elevated ECV suggesting that
the increased risk of heart failure in T2DM with micro-
albuminuria may be mediated cardiac fibrosis and extra-
cellular expansion.
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Table 1 Patient demographics shown as mean ± standard
deviation unless otherwise stated
ACR -ve ACR +ve P value
Age 61.5 ± 8.7 58.50 ± 12.60 0.23
Male gender, n (%) 38 (88) 32 (86) 0.80
Body mass index 28.4 ± 3.7 29.60 ± 4.80 0.21
Duration of Diabetes, years 4.6 ± 3.7 5.40 ± 4.50 0.57
HbA1c, mmols/mol 59.4 ± 12.6 65.40 ± 19.70 0.27
Blood pressure, mmHg 130/72 ± 23/8 134/75 ± 17/10 0.37/0.10
Table 2 LV volumes and ECV shown as mean ± standard
deviation unless otherwise stated
ACR -ve ACR +ve P value
End diastolic volume, ml 153.2 ± 32.4 151.8 ± 36.4 0.47
Ejection fraction, % 61.6 ± 5.3 59.7 ± 7.3 0.21
LV mass, g 95.4 ± 17.6 99.8 ± 25.2 0.52
Relative wall mass, g/ml 0.64 ± 0.13 0.67 ± 0.12 0.19
Precontrast T1 time, ms 1235.9 ± 40.3 1249.2 ± 66.6 0.46
ECV, % 25.1 ± 2.8 27.2 ± 4.2 0.01
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